Research Catalog

Title

Guidance for industry [electronic resource] : Q3B(R2) impurities in new drug products.

Publication

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

Details

Additional Authors

• Center for Drug Evaluation and Research (U.S.)
• Center for Biologics Evaluation and Research (U.S.)
• International Conference on Harmonisation.

Description

8 p. : digital, PDF file.

Alternative Title

• Q3B(R2) impurities in new drug products
• Impurities in new drug products

Subject

• Drug development > Government policy > United States
• Drug adulteration > Government policy > United States

Note

• Title from PDF title page (viewed on June 15, 2009).
• "ICH".
• "July 2006".
• "Revision 2".

System Details (note)

• Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL.

Call Number

GPO Internet HE 20.4702:IM 7/2

OCLC

399838071

Title

Guidance for industry [electronic resource] : Q3B(R2) impurities in new drug products.

Imprint

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006]

System Details

Mode of access: Internet at the FDA web site. Address as of 6/15/09: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm128033.pdf ; current access is available via PURL.

Connect to:

http://purl.access.gpo.gov/GPO/LPS113762

Added Author

Center for Drug Evaluation and Research (U.S.)

Center for Biologics Evaluation and Research (U.S.)

International Conference on Harmonisation.

Gpo Item No.

0499-T (online)

Sudoc No.

HE 20.4702:IM 7/2

Research Call Number

GPO Internet HE 20.4702:IM 7/2